In the sensitivity analysis, changing the effect models had no significant effects on the pooled ORs/HRs, and did not influence the final strength of association between XPG rs2296147T>C polymorphism and clinical outcomes of cancer patients. This evidence concerns the gene ERCC5 and cancer.